128 related articles for article (PubMed ID: 1078551)
1. Letter: Limitations of methotrexate and citrovorum-factor treatment.
Frei E; Jaffe NJ; Pitman S
N Engl J Med; 1975 Jan; 292(2):107-8. PubMed ID: 1078551
[No Abstract] [Full Text] [Related]
2. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
Djerassi I
N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
[No Abstract] [Full Text] [Related]
3. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
4. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
[No Abstract] [Full Text] [Related]
5. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Kickinger W; Ritschl P; Kotz R
Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
[TBL] [Abstract][Full Text] [Related]
6. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
7. [Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)].
Göbel U; Jürgens H; von Voss H; Wahn V; Rosen G
Klin Padiatr; 1981 Mar; 193(2):94-8. PubMed ID: 6971958
[No Abstract] [Full Text] [Related]
8. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Jaffe N; Frei E; Traggis D; Bishop Y
N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
[No Abstract] [Full Text] [Related]
9. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
Schremi W; Lohrmann HP
Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
11. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
Turman S; Coleman M; Silver RT; Pasmantier M
Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
13. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
[No Abstract] [Full Text] [Related]
14. Recent advances in the chemotherapy of metastatic osteogenic sarcoma.
Jaffe N
Cancer; 1972 Dec; 30(6):1627-31. PubMed ID: 4539306
[No Abstract] [Full Text] [Related]
15. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
16. Transient neurologic disturbances induced by high-dose methotrexate treatment.
Jaffe N; Takaue Y; Anzai T; Robertson R
Cancer; 1985 Sep; 56(6):1356-60. PubMed ID: 3875390
[TBL] [Abstract][Full Text] [Related]
17. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
Levi M; Sulkes A; Katz E; Rizel S; Biran S
Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
[TBL] [Abstract][Full Text] [Related]
19. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
[No Abstract] [Full Text] [Related]
20. Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
Jürgens H; Beron G; Winkler K
J Cancer Res Clin Oncol; 1983; 106 Suppl():14-8. PubMed ID: 6350313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
